ANAVEON AG
Biotechnology ResearchBasel, Switzerland11-50 Employees
A start up based in Switzerland that develops biologics to modulate the functions of cytokines and provide substantial therapeutic benefits to cancer patients.
Insights
Immunotherapy Expansion Anaveon's focus on developing biologics for cancer patients through immunotherapy presents a significant sales opportunity in the growing field of oncology treatments.
Clinical Study Progress The recent launch of ANV419 in the OMNIA-2 study and the ongoing development of follow-on compounds indicate a need for potential partnerships and collaborations, creating avenues for sales in clinical research services and drug development.
Key Personnel Additions The appointment of Dr. Eduard Gasal as Chief Medical Officer and Dr. Gary Phillips as Chief Business Officer highlights Anaveon's strategic investment in top talent, indicating a progressive approach that can attract potential investors or buyers.
Financial Strength With a substantial funding of $120M and revenue in the range of $0-$10M, Anaveon's financial stability can be leveraged to explore new markets, expand operations, or invest in innovative therapies - creating sales opportunities in financing and partnerships.
Competitive Analysis Positioned alongside similar biotech companies like iTeos Therapeutics and AlloVir, Anaveon can utilize market comparisons to showcase its unique offerings, potentially attracting investors, partners, or customers seeking differentiated solutions in the immuno-oncology space.
Similar companies to ANAVEON AG
iTeos Therapeutics
184
$10M$50MApplied Biological Materials
61$10MOrphazyme A/S
108Theradaptive
28$10MAlloVir
51$10M$50MPalleon Pharmaceuticals
29$10MMaaT Pharma
85$10M$50M
ANAVEON AG Tech Stack
ANAVEON AG uses 8 technology products and services including Google Font API, TweenMax, Open Graph, and more. Explore ANAVEON AG's tech stack below.
- Google Font APIFont Scripts
- TweenMaxJavascript Frameworks
- Open GraphMiscellaneous
- Yoast SEOSearch Engines
- X-XSS-ProtectionSecurity
- HSTSSecurity
- BootstrapUI Frameworks
- ApacheWeb Servers
Media & News
ANAVEON AG's Email Address Formats
ANAVEON AG uses at least 1 format(s):
| ANAVEON AG Email Formats | Percentage |
| First.Last@anaveon.com | 49% |
| First.Middle@anaveon.com | 1% |
| First.MiddleLast@anaveon.com | 1% |
| First.Last@anaveon.com | 49% |
Frequently Asked Questions
Where is ANAVEON AG's headquarters located?
ANAVEON AG's main headquarters is located at Technologiepark Basel, Hochbergerstrasse 60C Basel, 4057 CH. The company has employees across 1 continents, including Europe. What is ANAVEON AG's official website and social media links?
ANAVEON AG's official website is anaveon.com and has social profiles on LinkedIn.How much revenue does ANAVEON AG generate?
As of November 2024, ANAVEON AG's annual revenue reached $1.8M. What is ANAVEON AG's SIC code NAICS code?
ANAVEON AG's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does ANAVEON AG have currently?
As of November 2024, ANAVEON AG has approximately 25 employees across 1 continents, including Europe. Key team members include Chief Scientific Officer: C. H.Chief Medical Officer, Anaveon: E. G.Head Of Biomarkers And Bioanalytics: K. R.. Explore ANAVEON AG's employee directory with LeadIQ.What industry does ANAVEON AG belong to?
ANAVEON AG operates in the Biotechnology Research industry. What technology does ANAVEON AG use?
ANAVEON AG's tech stack includes Google Font APITweenMaxOpen GraphYoast SEOX-XSS-ProtectionHSTSBootstrapApache. What is ANAVEON AG's email format?
ANAVEON AG's email format typically follows the pattern of . Find more ANAVEON AG email formats with LeadIQ. How much funding has ANAVEON AG raised to date?
As of November 2024, ANAVEON AG has raised $120M in funding. The last funding round occurred on Dec 16, 2021 for $120M.When was ANAVEON AG founded?
ANAVEON AG was founded in 2017.
Company Overview
- Headquarters
- Technologiepark Basel, Hochbergerstrasse 60C Basel, 4057 CH
- Website
- anaveon.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2017
- Employees
- 11-50
Media & News
Funding & Financials
- $120M
ANAVEON AG has raised a total of $120M of funding over 2 rounds. Their latest funding round was raised on Dec 16, 2021 in the amount of $120M.
- $10M
ANAVEON AG's revenue is in the range of $10M
Funding & Financials
- $120M
ANAVEON AG has raised a total of $120M of funding over 2 rounds. Their latest funding round was raised on Dec 16, 2021 in the amount of $120M.
- $10M
ANAVEON AG's revenue is in the range of $10M
Company Leadership
C. H.Chief Scientific Officer- E. G.Chief Medical Officer, Anaveon
K. R.Head Of Biomarkers And Bioanalytics- A. K.Head Of Finance
- S. F. -.Head Of Corporate Affairs & Human Resources
Employee Directory
- S. F. -.Head Of Corporate Affairs & Human Resources
C. W.Senior Director Quality Assurance- P. G.It-Manager
- D. P.Clinical Trial Manager
- J. M.Clinical Trial Leader
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
